Aeglea BioTherapeutics Earning Date (AGLE)

USA |NASDAQ |USD

AGLE Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 2, 2022 Sep 2022 $-0.30 - $-0.31
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 2, 2022 Sep 2022 $540.00K - $1.40M

Aeglea Biotherapeutics's next earnings date is Wednesday, Nov 2, 2022 for the fiscal quarter ending Sep 2022.

AGLE Earnings Date & History Chart

AGLE Earnings & Revenue Forecast

AGLE Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 6 $-0.30 $-0.35 $-0.24
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 8 $-1.28 $-1.44 $-1.11
Dec 2023 7 $-1.00 $-1.37 $-0.57

AGLE Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Sep 2022 0 / 0 $-0.30 $-0.30 $-0.35
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-1.28 $-1.27 $-1.37
Dec 2023 0 / 0 $-1.00 $-1.02 $-1.16

AGLE Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Sep 2022 5 $540.00K $0.00 $1.50M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $2.93M $1.00M $5.86M
Dec 2023 5 $21.72M $10.00M $48.70M

AGLE Earnings Date & Revenue History

AGLE Earnings History

|
Show More
Show More

AGLE Revenue History

|
Show More
Show More

Aeglea Biotherapeutics Next Earnings Date & Report

AGLE Next Earnings Date & Report Preview: Sep 2022 (FQ)

AGLE's next earnings date is Wednesday, Nov 2, 2022 for the fiscal quarter ending Sep 30, 2022.

According to analysts, the average EPS estimation for Aeglea Biotherapeutics's next quarterly earnings is $-0.30, with a low EPS estimation of $-0.35, and a high estimation of $-0.24.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.30, the last 2 month trend is $-0.30, and the 3 month trend is $-0.35.

Based on analysts, the average revenue estimation is $540.00K, with a low revenue estimation of $0.00, and a high estimation of $1.50M.

Aeglea Biotherapeutics Previous Earnings Dates & Reports

AGLE Previous Earnings Date & Report Recap: Jun 2022 (FQ)

Aeglea Biotherapeutics's previous earnings date was Aug 3, 2022 for its fiscal quarter ended Jun 30, 2022.

AGLE Previous Earnings Date & Report Recap: Dec 2021 (FY)

Aeglea Biotherapeutics's previous annual earnings date was Mar 8, 2022 for its fiscal year ended Dec 31, 2021.

AGLE's earnings per share (EPS) was $-1.00, beating the consensus analysts forecast of $-1.00 by 0.00% , and higher than the previous year's EPS (Dec 2020) by -37.89%.

Revenues were $18.74M, better than the forecast of $18.30M by 2.40%, and up by 85689.50% from previous year's revenue.

The company reported a net income of $-65.80M.

Aeglea Biotherapeutics reported a free cash flow of $-54.29M for its fiscal year, compared to $-80.06M a year ago.

The company ended the fiscal year with $9.65M in total debt, an increase of 77.17% compared to the previous year.